International Conference Presentation

The Role of Adipose Tissue in the Development of Hyperandrogenism in women with polycystic ovarian syndrome

June 30, 2014
Source: 30th Annual Conference of the European Society of Human Reproduction and Embryology, 29 June - 2 July 2014, Munick, Germany

SAAD AMER, The Derby Medical School, Nottingham University
This important study presents new evidence of a signifcant role of the subcutanious fat (adipose) tissue in the production of excess androgen (male hormone) in women with polycystic ovarian syndrome

You can watch the presentation by clicking here.

Lapraroscopic Ovarian Diathermy Or Clomifene as First Line Treatment for Polycystic Ovarian Syndrome?

August 14, 2007
Source: 23rd Annual Conference of the European Society of Human Reproduction and Embryology, 1-4 July 2007, Lyon, France

SAAD AMER, The Derby Medical School, Nottingham University
More reassurance about the use of clomifene for treating anovulatory women with polycystic ovarian syndrome has emerged from a randomised study from Nottingham reported to the fertility conference held in Lyon. Laparoscopic ovarian diathermy, normally used as second line treatment (after clomifene), was found to be equivalent for inducing ovulation and pregnancy in a study with over sixty women. But Saad Amer explained to Sarah Maxwell why he still favours clomifene.

You can listen to the interview by clicking here.